Keeping Track: Approvals For Xultophy, Soliqua And Darzalex; NDAs From Intarcia And GSK; Complete Response For Green Cross

 
• By Bridget Silverman

The latest drug development news and highlights from our FDA Performance Tracker

More from Approvals

More from Product Reviews